Lynparza 50mg
Lynparza (olaparib) is a medicine utilized for the treatment of ovarian, fallopian tube, essential peritoneal malignant growth, and bosom disease.
Uses:
Lynparza (olaparib) is shown a poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of individuals with ovarian, fallopian cylinder or essential peritoneal malignant growth for the upkeep treatment of grown-up patients with a repetitive epithelial ovarian, fallopian cylinder or essential peritoneal disease, who are in a total or incomplete reaction to platinum-based chemotherapy ovarian malignancy for the treatment of grown-up patients with pernicious or suspected harmful germline BRCA-changed (gBRCAm) progressed ovarian malignant growth who have been treated with at least three earlier lines of chemotherapy bosom disease in patients with injurious or suspected malicious gBRCAm, human epidermal development factor receptor 2 (HER2)- negative metastatic bosom malignant growth who have recently been treated with chemotherapy.
